{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T07:45:40Z","timestamp":1790754340236,"version":"4.1.0"},"reference-count":28,"publisher":"American Medical Association (AMA)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"Importance<\/jats:title>Area-level measures of sociodemographic disadvantage may be associated with racial and ethnic disparities with respect to receipt of treatment for metastatic renal cell carcinoma (mRCC) but have not been investigated previously, to our knowledge.<\/jats:p><\/jats:sec>Objective<\/jats:title>To assess the association between area-level measures of social vulnerability and racial and ethnic disparities in the treatment of US Medicare beneficiaries with mRCC from 2015 through 2019.<\/jats:p><\/jats:sec>Design, Setting, and Participants<\/jats:title>This retrospective cohort study included Medicare beneficiaries older than 65 years who were diagnosed with mRCC from January 2015 through December 2019 and were enrolled in fee-for-service Medicare Parts A, B, and D from 1 year before through 1 year after presumed diagnosis or until death. Data were analyzed from November 22, 2022, through January 26, 2024.<\/jats:p><\/jats:sec>Exposures<\/jats:title>Five different county-level measures of disadvantage and 4 zip code\u2013level measures of vulnerability or deprivation and segregation were used to dichotomize whether an individual resided in the most vulnerable quartile according to each metric. Patient-level factors included age, race and ethnicity, sex, diagnosis year, comorbidities, frailty, Medicare and Medicaid dual enrollment eligibility, and Medicare Part D low-income subsidy (LIS).<\/jats:p><\/jats:sec>Main Outcomes and Measures<\/jats:title>The main outcomes were receipt and type of systemic therapy (oral anticancer agent or immunotherapy from 2 months before to 1 year after diagnosis of mRCC) as a function of patient and area-level characteristics. Multivariable regression analyses were used to adjust for patient factors, and odds ratios (ORs) from logistic regression and relative risk ratios (RRRs) from multinomial logistic regression are reported.<\/jats:p><\/jats:sec>Results<\/jats:title>The sample included 15\u202f407 patients (mean [SD] age, 75.6 [6.8] years), of whom 9360 (60.8%) were men; 6931 (45.0%), older than 75 years; 93 (0.6%), American Indian or Alaska Native; 257 (1.7%), Asian or Pacific Islander; 757 (4.9%), Hispanic; 1017 (6.6%), non-Hispanic Black; 12\u202f966 (84.2%), non-Hispanic White; 121 (0.8%), other; and 196 (1.3%), unknown. Overall, 8317 patients (54.0%) received some type of systemic therapy. After adjusting for individual factors, no county or zip code\u2013level measures of social vulnerability, deprivation, or segregation were associated with disparities in treatment. In contrast, patient-level factors, including female sex (OR, 0.78; 95% CI, 0.73-0.84) and LIS (OR, 0.48; 95% CI, 0.36-0.65), were associated with lack of treatment, with particularly limited access to immunotherapy for patients with LIS (RRR, 0.25; 95% CI, 0.14-0.43). Associations between individual-level factors and treatment in multivariable analysis were not mediated by the addition of area-level metrics. Disparities by race and ethnicity were consistently and only observed within the most vulnerable areas, as indicated by the top quartile of each vulnerability deprivation index.<\/jats:p><\/jats:sec>Conclusions and Relevance<\/jats:title>In this cohort study of older Medicare patients diagnosed with mRCC, individual-level demographics, including race and ethnicity, sex, and income, were associated with receipt of systemic therapy, whereas area-level measures were not. However, individual-level racial and ethnic disparities were largely limited to socially vulnerable areas, suggesting that efforts to improve racial and ethnic disparities may be most effective when targeted to socially vulnerable areas.<\/jats:p><\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2024.8747","type":"journal-article","created":{"date-parts":[[2024,4,30]],"date-time":"2024-04-30T15:35:47Z","timestamp":1714491347000},"page":"e248747","source":"Crossref","is-referenced-by-count":5,"title":["Area Vulnerability and Disparities in Therapy for Patients With Metastatic Renal Cell Carcinoma"],"prefix":"10.1001","volume":"7","author":[{"given":"Syed N.","family":"Rahman","sequence":"first","affiliation":[{"name":"Department of Urology, Yale School of Medicine, New Haven, Connecticut"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica B.","family":"Long","sequence":"additional","affiliation":[{"name":"Yale Cancer Outcomes, Public Policy, and Effectiveness Research Center, Yale University, New Haven, Connecticut"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah J.","family":"Westvold","sequence":"additional","affiliation":[{"name":"Yale Cancer Outcomes, Public Policy, and Effectiveness Research Center, Yale University, New Haven, Connecticut"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael S.","family":"Leapman","sequence":"additional","affiliation":[{"name":"Department of Urology, Yale School of Medicine, New Haven, Connecticut"},{"name":"Yale Cancer Outcomes, Public Policy, and Effectiveness Research Center, Yale University, New Haven, Connecticut"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa P.","family":"Spees","sequence":"additional","affiliation":[{"name":"Department of Health Policy and Management, Gillings School of Global Public Health, The University of North Carolina at Chapel Hill"},{"name":"Lineberger Comprehensive Cancer Center, The University of North Carolina at Chapel Hill"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael E.","family":"Hurwitz","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah D.","family":"McManus","sequence":"additional","affiliation":[{"name":"Department of Medicine, Duke University School of Medicine, Durham, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cary P.","family":"Gross","sequence":"additional","affiliation":[{"name":"Yale Cancer Outcomes, Public Policy, and Effectiveness Research Center, Yale University, New Haven, Connecticut"},{"name":"Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie B.","family":"Wheeler","sequence":"additional","affiliation":[{"name":"Department of Health Policy and Management, Gillings School of Global Public Health, The University of North Carolina at Chapel Hill"},{"name":"Lineberger Comprehensive Cancer Center, The University of North Carolina at Chapel Hill"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michaela A.","family":"Dinan","sequence":"additional","affiliation":[{"name":"Yale Cancer Outcomes, Public Policy, and Effectiveness Research Center, Yale University, New Haven, Connecticut"},{"name":"Department of Chronic Disease Epidemiology, Yale School of Public Health, New Haven, Connecticut"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2024,4,30]]},"reference":[{"key":"zoi240324r1","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.urology.2021.08.070","article-title":"Disparities in the treatment and survival of metastatic renal cell carcinoma.","volume":"165","author":"Metcalf","year":"2022","journal-title":"Urology"},{"issue":"19","key":"zoi240324r2","doi-asserted-by":"publisher","first-page":"2988","DOI":"10.1002\/cncr.v122.19","article-title":"Racial disparities in survival among patients with advanced renal cell carcinoma in the targeted therapy era.","volume":"122","author":"Rose","year":"2016","journal-title":"Cancer"},{"issue":"3","key":"zoi240324r3","doi-asserted-by":"publisher","DOI":"10.1093\/jncics\/pkad036","article-title":"Disparities in immune and targeted therapy utilization for older US patients with metastatic renal cell carcinoma.","volume":"7","author":"Chow","year":"2023","journal-title":"J Natl Cancer Inst Cancer Spectr"},{"issue":"2","key":"zoi240324r4","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1002\/msj.v77:2","article-title":"Access to health and health care: how race and ethnicity matter.","volume":"77","author":"Richardson","year":"2010","journal-title":"Mt Sinai J Med"},{"issue":"5","key":"zoi240324r5","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1093\/jnci\/94.5.334","article-title":"Racial and ethnic disparities in the receipt of cancer treatment.","volume":"94","author":"Shavers","year":"2002","journal-title":"J Natl Cancer Inst"},{"issue":"4","key":"zoi240324r6","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2023.8908","article-title":"Neighborhood disadvantage and breast cancer-specific survival.","volume":"6","author":"Goel","year":"2023","journal-title":"JAMA Netw Open"},{"issue":"6","key":"zoi240324r7","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1097\/SLA.0000000000004691","article-title":"County-level social vulnerability is associated with worse surgical outcomes especially among minority patients.","volume":"274","author":"Diaz","year":"2021","journal-title":"Ann Surg"},{"issue":"4","key":"zoi240324r8","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/j.ajog.2023.04.026","article-title":"Role of neighborhood context in ovarian cancer survival disparities: current research and future directions.","volume":"229","author":"Gomez","year":"2023","journal-title":"Am J Obstet Gynecol"},{"issue":"12","key":"zoi240324r9","doi-asserted-by":"publisher","first-page":"1943","DOI":"10.1016\/j.vaccine.2023.02.022","article-title":"Minority Health Social Vulnerability Index and COVID-19 vaccination coverage\u2014the United States, December 14, 2020-January 31, 2022.","volume":"41","author":"Saelee","year":"2023","journal-title":"Vaccine"},{"issue":"2","key":"zoi240324r10","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1007\/s11524-016-0116-z","article-title":"Local residential segregation matters: stronger association of Census tract compared to conventional city-level measures with fatal and non-fatal assaults (total and firearm related), using the Index of Concentration at the Extremes (ICE) for racial, economic, and racialized economic segregation, Massachusetts (US), 1995-2010.","volume":"94","author":"Krieger","year":"2017","journal-title":"J Urban Health"},{"issue":"1","key":"zoi240324r13","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0262962","article-title":"Racialized economic segregation and health outcomes: a systematic review of studies that use the Index of Concentration at the Extremes for race, income, and their interaction.","volume":"17","author":"Larrabee Sonderlund","year":"2022","journal-title":"PLoS One"},{"issue":"9","key":"zoi240324r14","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.33429","article-title":"County-level social vulnerability and breast, cervical, and colorectal cancer screening rates in the US, 2018.","volume":"5","author":"Bauer","year":"2022","journal-title":"JAMA Netw Open"},{"issue":"16","key":"zoi240324r16","doi-asserted-by":"publisher","first-page":"6534","DOI":"10.1200\/JCO.2022.40.16_suppl.6534","article-title":"Association of US county social vulnerability with cancer mortality.","volume":"40","author":"Mehta","year":"2022","journal-title":"J Clin Oncol"},{"issue":"4","key":"zoi240324r17","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1097\/SLA.0000000000005375","article-title":"Structural racism and breast cancer-specific survival: impact of economic and racial residential segregation.","volume":"275","author":"Goel","year":"2022","journal-title":"Ann Surg"},{"issue":"7","key":"zoi240324r18","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.20908","article-title":"Association between residence in historically redlined districts indicative of structural racism and racial and ethnic disparities in breast cancer outcomes.","volume":"5","author":"Plascak","year":"2022","journal-title":"JAMA Netw Open"},{"issue":"6","key":"zoi240324r19","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1097\/SLA.0000000000004653","article-title":"The impact of racial residential segregation on colorectal cancer outcomes and treatment.","volume":"273","author":"Poulson","year":"2021","journal-title":"Ann Surg"},{"issue":"3","key":"zoi240324r20","first-page":"27","article-title":"More accurate racial and ethnic codes for Medicare administrative data.","volume":"29","author":"Eicheldinger","year":"2008","journal-title":"Health Care Financ Rev"},{"issue":"9","key":"zoi240324r21","doi-asserted-by":"publisher","first-page":"2878","DOI":"10.1007\/s11999-014-3686-7","article-title":"The Elixhauser comorbidity method outperforms the Charlson index in predicting inpatient death after orthopaedic surgery.","volume":"472","author":"Menendez","year":"2014","journal-title":"Clin Orthop Relat Res"},{"issue":"1","key":"zoi240324r22","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1097\/00005650-199801000-00004","article-title":"Comorbidity measures for use with administrative data.","volume":"36","author":"Elixhauser","year":"1998","journal-title":"Med Care"},{"issue":"7","key":"zoi240324r23","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1093\/gerona\/glx229","article-title":"Measuring frailty in Medicare data: development and validation of a claims-based frailty index.","volume":"73","author":"Kim","year":"2018","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"1","key":"zoi240324r24","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1002\/cam4.2018.7.issue-1","article-title":"Association of high cost sharing and targeted therapy initiation among elderly Medicare patients with metastatic renal cell carcinoma.","volume":"7","author":"Li","year":"2018","journal-title":"Cancer Med"},{"key":"zoi240324r25","doi-asserted-by":"publisher","DOI":"10.1017\/dmp.2023.29","article-title":"Measuring historic and longitudinal social vulnerability in disaster-prone communities: a modification to the Centers for Disease Control and Prevention Social Vulnerability Index (CDC-SVI).","volume":"17","author":"Adepoju","year":"2023","journal-title":"Disaster Med Public Health Prep"},{"issue":"2","key":"zoi240324r26","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1245\/s10434-020-08860-5","article-title":"Association of neighborhood characteristics with utilization of high-volume hospitals among patients undergoing high-risk cancer surgery.","volume":"28","author":"Diaz","year":"2021","journal-title":"Ann Surg Oncol"},{"issue":"11","key":"zoi240324r27","doi-asserted-by":"publisher","first-page":"6309","DOI":"10.1245\/s10434-021-09911-1","article-title":"Impact of race\/ethnicity and county-level vulnerability on receipt of surgery among older Medicare beneficiaries with the diagnosis of early pancreatic cancer.","volume":"28","author":"Azap","year":"2021","journal-title":"Ann Surg Oncol"},{"issue":"12","key":"zoi240324r28","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.39593","article-title":"Neighborhood and individual socioeconomic disadvantage and survival among patients with nonmetastatic common cancers.","volume":"4","author":"Cheng","year":"2021","journal-title":"JAMA Netw Open"},{"key":"zoi240324r11","author":"Flanagan","year":"2011"},{"key":"zoi240324r12","year":"2018"},{"key":"zoi240324r15","author":"Zyczynski","year":"2022"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2818069\/rahman_2024_oi_240324_1713448553.74136.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,30]],"date-time":"2024-04-30T15:35:52Z","timestamp":1714491352000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2818069"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,30]]},"references-count":28,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,4,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2024.8747","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,30]]}}}